Ritu Salani, Mansoor Raza Mirza, Zhongqiu Lin, Shin Nishio, Ana Oaknin, Jean Emmanuel Kurtz, Giorgio Valabrega, Valeria Cáceres, Philipp Harter, Lucy Gilbert, Azmat Sadozye, Lilian Arruda De Rêgo Barros, Toon Van Gorp, Ingrid A. Boere, Christian Marth, Linda R. Duska, Bradley J. Monk, Xin Tong Li, Cumhur Tekin, Kristina Lindemann. "TroFuse-020/GOG-3101/ENGOT-cx20: A phase 3, randomized, active-controlled, open-label, multicenter study comparing sacituzumab tirumotecan monotherapy vs treatment of physician’s choice as second-line treatment for recurrent or metastatic cervical cancer.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.tps5618